Article
Human TH9 differentiation is dependent on signal transducer and activator of transcription (STAT) 3 to restrain STAT1-mediated inhibition.
The Journal of allergy and clinical immunology - 1 Mar 2019
Zhang Yuan, Siegel Andrea M, Sun Guangping, Dimaggio Tom, Freeman Alexandra F, Milner Joshua D
Abstract excerpt
BACKGROUND: Patients with loss-of-function (LOF) signal transducer and activator of transcription 3 (STAT3) mutations have dermatitis, enhanced IgE production despite a relative lack of immediate hypersensitivity, recurrent infection, and an increased rate of lymphoma in addition to a number of skeletal and connective tissue abnormalities. Patients with STAT1 gain-of-function (GOF) mutations also have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
